EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities

Bianca Garlisi, Sylvia Lauks, Caroline Aitken, Leslie M Ogilvie iD, Cielle Lockington, Duncan Petrik, Jan Soeren Eichhorn, Jim Petrik iD

Current Oncology · 01.07.2024 · 31 (7) · 3826-3844

DOI: 10.3390/curroncol31070283 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 01.07.2024. Verfasst von Bianca Garlisi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of Guelph, Guelph, ON N1G 2W1, Canada. Hauptthemen laut MEDLINE: Tumor Microenvironment, Ovarian Neoplasms. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Canadian Institutes of Health Research, Ovarian Cancer Canada, the Cancer Research Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The tumor microenvironment (TME) in ovarian cancer (OC) has much greater complexity than previously understood. In response to aggressive pro-angiogenic stimulus, blood vessels form rapidly and are dysfunctional, resulting in poor perfusion, tissue hypoxia, and leakiness, which leads to increased interstitial fluid pressure (IFP). Decreased perfusion and high IFP significantly inhibit the uptake of therapies into the tumor. Within the TME, there are numerous inhibitor cells, such as myeloid-derived suppressor cells (MDSCs), tumor association macrophages (TAMs), regulatory T cells (Tregs), and cancer-associated fibroblasts (CAFs) that secrete high numbers of immunosuppressive cytokines. This immunosuppressive environment is thought to contribute to the lack of success of immunotherapies such as immune checkpoint inhibitor (ICI) treatment. This review discusses the components of the TME in OC, how these characteristics impede therapeutic efficacy, and some strategies to alleviate this inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentOvarian NeoplasmsHumansFemaleImmunotherapy

Stichwörter der Autor:innen

immunosuppressioninterstitial fluid pressureovarian cancertumor angiogenesistumor microenvironmentvascular normalization

Autor:innen und Institutionen

  • Department of Biomedical Sciences, University of Guelph, Guelph, ON N1G 2W1, Canada.

ORCID-Profile: Leslie M Ogilvie, Jim Petrik

Förderung

  • the Canadian Institutes of Health Research
  • Ovarian Cancer Canada
  • the Cancer Research Society

Zitieren

APA

Garlisi, B., Lauks, S., Aitken, C., Ogilvie, L. M., Lockington, C., Petrik, D., Eichhorn, J. S., & Petrik, J. (2024). The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities. Current Oncology, 31(7), 3826-3844. https://doi.org/10.3390/curroncol31070283

Vancouver

Garlisi B, Lauks S, Aitken C, Ogilvie LM, Lockington C, Petrik D, et al. The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities. Current Oncology. 2024;31(7):3826-3844. doi:10.3390/curroncol31070283

BibTeX
@article{Garlisi2024,
  author = {Garlisi, Bianca and Lauks, Sylvia and Aitken, Caroline and Ogilvie, Leslie M and Lockington, Cielle and Petrik, Duncan and Eichhorn, Jan Soeren and Petrik, Jim},
  title = {The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities},
  journal = {Current Oncology},
  year = {2024},
  volume = {31},
  number = {7},
  pages = {3826--3844},
  doi = {10.3390/curroncol31070283}
}
Kostenlos starten →